Lophius Biosciences GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lophius Biosciences GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10575
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets T cell-based diagnostic systems and research tools in the areas of transplantation, infectious and autoimmune diseases. The company’s T-track immunoscan assay is a test in natural or induced immune modulation to evaluate the functionality of cell mediated immunity. Its T-track CMV is a diagnostic test to measure CMV-specific cell mediated immunity. Lophius provides T cell tools such as ELISpot kits, T cell stimulants, and custom ELISpot kit. The company offers services including antigen selection, optimization, immune assay development and therapy monitoring. It markets its products through its specialized marketing and distribution partners in Germany, Spain, the Netherlands, Belgium, Luxemburg and Korea. Lophius is headquartered in Regensburg, Germany.

Lophius Biosciences GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lophius Biosciences GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Lophius Biosciences Raises USD2.4 Million in First Tranche of Venture Financing 11
Lophius Biosciences Raises USD4.66 Million in Venture Financing 12
Lophius Biosciences Raises Funds through Venture Financing 13
Lophius Biosciences Raises US$2.8 Million In Venture Financing 14
Lophius Biosciences Raises USD5.3 Million in Series C Financing Round 15
Lophius Biosciences GmbH – Key Competitors 16
Lophius Biosciences GmbH – Key Employees 17
Lophius Biosciences GmbH – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Mar 22, 2017: Lophius Biosciences Appoints Robert J. Silverman as Supervisory Board Member 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Lophius Biosciences GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Lophius Biosciences Raises USD2.4 Million in First Tranche of Venture Financing 11
Lophius Biosciences Raises USD4.66 Million in Venture Financing 12
Lophius Biosciences Raises Funds through Venture Financing 13
Lophius Biosciences Raises US$2.8 Million In Venture Financing 14
Lophius Biosciences Raises USD5.3 Million in Series C Financing Round 15
Lophius Biosciences GmbH, Key Competitors 16
Lophius Biosciences GmbH, Key Employees 17

List of Figures
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lophius Biosciences GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Lophius Biosciences GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Honda Motor Co Inc:企業の戦略的SWOT分析
    American Honda Motor Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Bunge Ltd (BG):企業の財務・戦略的SWOT分析
    Bunge Ltd (BG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • METRO Retail Stores Group Inc (MRSGI):企業の財務・戦略的SWOT分析
    METRO Retail Stores Group Inc (MRSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Reliance General Insurance Company Ltd:企業の戦略・SWOT・財務情報
    Reliance General Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Reliance General Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Old Dominion Freight Line, Inc. (ODFL):企業の財務・戦略的SWOT分析
    Old Dominion Freight Line, Inc. (ODFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Consolidated Edison Inc (ED):石油・ガス:M&Aディール及び事業提携情報
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …
  • TOTAL S.A.:戦略・SWOT・企業財務分析
    TOTAL S.A. - Strategy, SWOT and Corporate Finance Report Summary TOTAL S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Obalon Therapeutics Inc (OBLN):医療機器:M&Aディール及び事業提携情報
    Summary Obalon Therapeutics Inc (Obalon Therapeutics) is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gast …
  • Belden Inc (BDC):企業の財務・戦略的SWOT分析
    Belden Inc (BDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Invicta Holdings Limited:企業の戦略・SWOT・財務情報
    Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sangui BioTech International Inc (SGBI):企業の財務・戦略的SWOT分析
    Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ability Pharmaceuticals SL-製薬・医療分野:企業M&A・提携分析
    Summary Ability Pharmaceuticals SL (Ability Pharma), formerly known as AB Therapeutics S.L., is a clinical stage biopharmaceutical company that focuses on drug discovery and development. It develops human therapeutics to treat lung, pancreatic and gynecological cancers. The company’s lead pipeline p …
  • Axela Inc:医療機器:M&Aディール及び事業提携情報
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Swelect Energy Systems Ltd (SWELECTES):企業の財務・戦略的SWOT分析
    Summary Swelect Energy Systems Ltd(SESL), is an energy company that manufactures and markets renewable energy products and iron and steel products. The company’s renewable energy products include solar pv modules, solar inverter, solar water pump and energy efficient lighting. SESL offers iron and s …
  • Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Antero Resources Corp (Antero) is an independent oil and natural gas company that explores, develops, produces and sells natural gas and oil from the Appalachia Basin. It gather and process wel …
  • AB Volvo:戦略・SWOT・企業財務分析
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Nestle Health Science SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …
  • Caterpillar Inc (CAT):企業の財務・戦略的SWOT分析
    Caterpillar Inc (CAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • National Petroleum Construction Co:企業の戦略・SWOT・財務情報
    National Petroleum Construction Co - Strategy, SWOT and Corporate Finance Report Summary National Petroleum Construction Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆